- Conditions
- Sickle Cell Disease
- Interventions
- Crizanlizumab
- Other
- Lead sponsor
- Andria Ford
- Other
- Eligibility
- 16 Years and older
- Enrollment
- 31 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2025
- U.S. locations
- 1
- States / cities
- St Louis, Missouri
Source: ClinicalTrials.gov public record
Updated Mar 5, 2023 · Synced May 22, 2026, 3:49 AM EDT